The biological functions and pathological impacts of ARID1A variations on CRC might be correlated to the co-occurrence variation of other genes (i.e., TP53 and KRAS) and the regulation of signaling pathways (i.e., Akt signaling and WNT signaling). Here, AKT1 is linked to colorectal carcinoma.